. Author manuscript; available in PMC: 2011 Jan 1.

Published in final edited form as: Breast Cancer Res Treat. 2009 Apr 21;119(2):431–436. doi: 10.1007/s10549-009-0397-y

Table 4.

Comparisons of mtDNA D-loop MnlI RFLP pattern changes between breast cancer patients and BBD patients, between different TNM stages among breast cancer patients, and between different types of BBD patients

	N	RFLP pattern change^a, N (%)	OR (95% CI)
Breast cancer vs BBD
BBD	59	9 (15.3%)	1.00 (reference)
Breast Cancer	120	34 (28.3%)	2.23 (0.95–5.22)
In breast cancer patients
TNM > I	30	5 (16.7%)	1.00 (reference)
TNM = 0 & I	90	29 (32.2%)	2.40 (0.82–6.97)
In BBD patients
Proliferative	23	3 (13.0%)	1.00 (reference)
Non-proliferative	28	2 (7.1%)	0.48 (0.07–3.37)

The difference of MnlI RFLP patterns between tumor tissues and the corresponding adjacent non-tumor tissues.